{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T16:27:59Z","timestamp":1794414479890,"version":"4.9.1"},"reference-count":172,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.pharmthera.2026.109103","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:11:20Z","timestamp":1788221480000},"page":"109103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prospects for treatment of cerebral ischemic stroke with Hydroxysafflower Yellow A"],"prefix":"10.1016","volume":"288","author":[{"given":"Beibei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengfang","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cungen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2026.109103_bb0005","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/1440-1681.13500","article-title":"Targeting autophagy in neurodegenerative diseases: From molecular mechanisms to clinical therapeutics","volume":"48","author":"Ajoolabady","year":"2021","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-immunol-030409-101323","article-title":"HMGB1 is a therapeutic target for sterile inflammation and infection","volume":"29","author":"Andersson","year":"2011","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0015","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuro.2019.12.004","article-title":"Ropinirole induces neuroprotection following reperfusion-promoted mitochondrial dysfunction after focal cerebral ischemia in Wistar rats","volume":"77","author":"Andrabi","year":"2020","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109103_bb0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.15252\/embr.201744705","article-title":"The unique histidine in OSCP subunit of F-ATP synthase mediates inhibition of the permeability transition pore by acidic pH","volume":"19","author":"Antoniel","year":"2018","journal-title":"EMBO Reports"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0025","doi-asserted-by":"crossref","first-page":"01265","DOI":"10.3389\/fphar.2020.01265","article-title":"Therapeutic potential of Hydroxysafflor Yellow A on cardio-cerebrovascular diseases","volume":"11","author":"Bai","year":"2020","journal-title":"Frontiers in Pharmacology"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109103_bb0030","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/ni.2919","article-title":"The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response","volume":"15","author":"Baroja-Mazo","year":"2014","journal-title":"Nature Immunology"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0035","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: A report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109103_bb0040","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ana.25073","article-title":"Stroke-induced chronic systolic dysfunction driven by sympathetic overactivity","volume":"82","author":"Bieber","year":"2017","journal-title":"Annals of Neurology"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109103_bb0045","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/CIRCULATIONAHA.106.603431","article-title":"Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke","volume":"115","author":"Caso","year":"2007","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.pharmthera.2026.109103_bb0050","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1212\/01.wnl.0000326064.42186.7e","article-title":"High plasma glutamate concentrations are associated with infarct growth in acute ischemic stroke","volume":"71","author":"Castellanos","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0055","article-title":"Early dysregulation of GSK3\u03b2 impairs mitochondrial activity in Fragile X Syndrome","volume":"106726","author":"Cencelli","year":"2024","journal-title":"Neurobiology of Disease"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109103_bb0060","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S1474-4422(16)00114-9","article-title":"Neuroprotection in acute stroke: Targeting excitotoxicity, oxidative and nitrosative stress, and inflammation","volume":"15","author":"Chamorro","year":"2016","journal-title":"The Lancet Neurology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109103_bb0065","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/10641955.2019.1584630","article-title":"Increased circulating trimethylamine N-oxide plays a contributory role in the development of endothelial dysfunction and hypertension in the RUPP rat model of preeclampsia","volume":"38","author":"Chen","year":"2019","journal-title":"Hypertension in Pregnancy"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109103_bb0070","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1007\/s11064-013-1135-8","article-title":"Hydroxysafflor yellow A protects against cerebral ischemia-reperfusion injury by anti-apoptotic effect through PI3K\/Akt\/GSK3\u03b2 pathway in rat","volume":"38","author":"Chen","year":"2013","journal-title":"Neurochemical Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109103_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134694","article-title":"Mitochondrial apoptotic pathway is activated by H2O2-Mediated oxidative stress in BmN-SWU1 cells from Bombyx mori Ovary","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109103_bb0080","first-page":"3009","article-title":"Neuroprotection of hydroxysafflor yellow A in experimental cerebral ischemia\/reperfusion injury via metabolic inhibition of phenylalanine and mitochondrial biogenesis","volume":"19","author":"Chen","year":"2019","journal-title":"Molecular Medicine Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109103_bb0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13041-020-00601-9","article-title":"Arginine is neuroprotective through suppressing HIF-1\u03b1\/LDHA-mediated inflammatory response after cerebral ischemia\/reperfusion injury","volume":"13","author":"Chen","year":"2020","journal-title":"Molecular Brain"},{"issue":"5-6","key":"10.1016\/j.pharmthera.2026.109103_bb0090","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000452408","article-title":"Hydroxysafflor Yellow A Promotes Angiogenesis via the Angiopoietin 1\/ Tie-2 Signaling Pathway","volume":"53","author":"Chen","year":"2016","journal-title":"Journal of Vascular Research"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0095","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuint.2019.01.005","article-title":"Inhibition of miR-497 improves functional outcome after ischemic stroke by enhancing neuronal autophagy in young and aged rats","volume":"127","author":"Chen","year":"2019","journal-title":"Neurochemistry International"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109103_bb0105","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCRESAHA.117.311170","article-title":"Brain-Heart interaction: Cardiac complications after stroke","volume":"121","author":"Chen","year":"2017","journal-title":"Circulation Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109103_bb0110","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cell.2013.06.037","article-title":"Role of PFKFB3-driven glycolysis in vessel sprouting","volume":"154","author":"De Bock","year":"2013","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109103_bb0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11064-025-04452-5","article-title":"Hydroxysafflor Yellow A ameliorates ischemic stroke by inhibiting NLRP3, AIM2, and Pyrin inflammasome-mediated pyroptosis","volume":"50","author":"Ding","year":"2025","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101107","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis","volume":"23","author":"Dodson","year":"2019","journal-title":"Redox Biology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109103_bb0125","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0254-6272(18)30992-0","article-title":"Comparative study of the effects of Danhong injection with different doses on ischemic stroke: A substudy of hospital-based Danhong injection registry","volume":"38","author":"Du","year":"2018","journal-title":"Journal of Traditional Chinese Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109103_bb0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41419-024-07314-0","article-title":"Correction: Drp1 regulates mitochondrial dysfunction and dysregulated metabolism in ischemic injury via Clec16a-, BAX-, and GSH- pathways","volume":"16","author":"Duan","year":"2025","journal-title":"Cell Death & Disease"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109103_bb0135","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/CIRCRESAHA.121.319994","article-title":"Immune pathways in etiology, acute phase, and chronic sequelae of ischemic stroke","volume":"130","author":"Endres","year":"2022","journal-title":"Circulation Research"},{"issue":"14","key":"10.1016\/j.pharmthera.2026.109103_bb0140","article-title":"Stroke related brain-heart crosstalk: Pathophysiology, clinical implications, and underlying mechanisms","volume":"11","author":"Fan","year":"2024","journal-title":"Adv. Sci. Weinh. Baden-Wurtt. Ger."},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109103_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007230.pub2","article-title":"Edaravone for acute ischaemic stroke","volume":"2011","author":"Feng","year":"2011","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0150","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.phrs.2018.11.006","article-title":"Danhong injection in cardiovascular and cerebrovascular diseases: Pharmacological actions, molecular mechanisms, and therapeutic potential","volume":"139","author":"Feng","year":"2019","journal-title":"Pharmacological Research"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109103_bib886","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S1474-4422(24)00369-7","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990-2021: A systematic analysis for the global burden of diease study 2021","volume":"23","year":"2024","journal-title":"Lancet Neurology"},{"issue":"Pt A","key":"10.1016\/j.pharmthera.2026.109103_bb0155","article-title":"The activation of the HIF-1\u03b1-VEGFA-Notch1 signaling pathway by Hydroxysafflor yellow A promotes angiogenesis and reduces myocardial ischemia-reperfusion injury","volume":"142","author":"Ge","year":"2024","journal-title":"International Immunopharmacology"},{"issue":"15","key":"10.1016\/j.pharmthera.2026.109103_bb0160","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.3390\/nu15153411","article-title":"Hydroxysafflor Yellow A Alleviates Acute Myocardial Ischemia\/Reperfusion Injury in Mice by Inhibiting Ferroptosis via the Activation of the HIF-1\u03b1\/SLC7A11\/GPX4 Signaling Pathway","volume":"15","author":"Ge","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157011","article-title":"The protective mechanism of Hydroxysafflor yellow A for the treatment of stroke - heart - syndrome via activating the ZBP1-NLRP3 signaling pathway","volume":"145","author":"Ge","year":"2025","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109103_bb0170","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12035-025-05592-z","article-title":"The breakdown of neurovascular barriers: Molecular mechanisms of tight junction dysfunction","volume":"63","author":"Gopal","year":"2025","journal-title":"Molecular Neurobiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109103_bb0175","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1568007053544156","article-title":"Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers","volume":"4","author":"Green","year":"2005","journal-title":"Current Drug Targets. CNS and Neurological Disorders"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0180","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3389\/fpls.2017.01409","article-title":"Overexpression of CtCHS1 increases accumulation of Quinochalcone in Safflower","volume":"8","author":"Guo","year":"2017","journal-title":"Frontiers in Plant Science"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109103_bb0185","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s11655-023-3716-y","article-title":"Hydroxysafflor Yellow A inhibits pyroptosis and protecting HUVECs from OGD\/R via NLRP3\/Caspase-1\/GSDMD pathway","volume":"30","author":"Guo","year":"2024","journal-title":"Chinese Journal of Integrative Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109103_bb0190","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s12975-020-00863-4","article-title":"Disruptions of anaerobic gut bacteria are associated with stroke and post-stroke infection: A prospective case-control study","volume":"12","author":"Haak","year":"2021","journal-title":"Translational Stroke Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109103_bb0195","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/cancers13061292","article-title":"Targeting BCL-2 in cancer: Advances, challenges, and perspectives","volume":"13","author":"Hafezi","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0200","article-title":"Signaling pathways in brain ischemia: Mechanisms and therapeutic implications","volume":"251","author":"Han","year":"2023","journal-title":"Pharmacology & Therapeutics"},{"issue":"03","key":"10.1016\/j.pharmthera.2026.109103_bb0205","first-page":"275","article-title":"Protective effect and mechanism of hydroxysafflor yellow A on astrocytes after OGD\/R","volume":"38","author":"Han","year":"2022","journal-title":"Chinese Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0210","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neulet.2018.02.003","article-title":"Deregulation of synaptic plasticity in autism","volume":"688","author":"Hansel","year":"2019","journal-title":"Neuroscience Letters"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109103_bb0215","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/1673-5374.264442","article-title":"Angiogenesis and neuronal remodeling after ischemic stroke","volume":"15","author":"Hatakeyama","year":"2020","journal-title":"Neural Regeneration Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109103_bb0220","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3797\/scipharm.0811-01","article-title":"Effect of cerebral ischemia\/reperfusion injury on hydroxysafflor Yellow A penetrating across the blood-brain barrier","volume":"76","author":"He","year":"2008","journal-title":"Scientia Pharmaceutica"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0225","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.2147\/JIR.S461427","article-title":"Mechanisms of postischemic stroke angiogenesis: A multifaceted approach","volume":"17","author":"Hu","year":"2024","journal-title":"Journal of Inflammation Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109103_bb0230","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11655-020-3094-7","article-title":"Effect and Safety of Hydroxysafflor Yellow A for injection in patients with acute ischemic stroke of blood stasis syndrome: A Phase II, multicenter, randomized, double-blind, multiple-dose, active-controlled clinical trial","volume":"26","author":"Hu","year":"2020","journal-title":"Chinese Journal of Integrative Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109103_bb0235","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3892\/ijmm.2016.2584","article-title":"Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt\/Nrf2\/HO-1 pathway","volume":"38","author":"Hu","year":"2016","journal-title":"International Journal of Molecular Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109103_bb0240","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s12035-022-03200-y","article-title":"An updated review of mitochondrial transplantation as a potential therapeutic strategy against cerebral ischemia and cerebral ischemia\/reperfusion injury","volume":"60","author":"Huang","year":"2023","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153532","article-title":"Hydroxysafflor Yellow A alleviates cerebral ischemia reperfusion injury by suppressing apoptosis via mitochondrial permeability transition pore","volume":"85","author":"Huang","year":"2021","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109103_bb0250","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/FJC.0b013e318181fb02","article-title":"Hydroxysafflor Yellow A enhances survival of vascular endothelial cells under hypoxia via upregulation of the HIF-1 alpha-VEGF pathway and regulation of Bcl-2\/Bax","volume":"52","author":"Ji","year":"2008","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109103_bb0255","first-page":"2006","article-title":"Modulators of microglia activation and polarization in ischemic stroke (Review)","volume":"21","author":"Jiang","year":"2020","journal-title":"Molecular Medicine Reports"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109103_bb0260","doi-asserted-by":"crossref","first-page":"16929","DOI":"10.4238\/2015.December.14.21","article-title":"Effects of Danhong injection on hemodynamics and the inflammation-related NF-\u03baB signaling pathway in patients with acute cerebral infarction","volume":"14","author":"Jiang","year":"2015","journal-title":"Genetics and Molecular Research: GMR"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109103_bb0265","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1161\/STROKEAHA.112.664318","article-title":"Serious cardiac arrhythmias after stroke: incidence, time course, and predictors--a systematic, prospective analysis","volume":"43","author":"Kallm\u00fcnzer","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2026.04.034","article-title":"Microglia-driven neuroinflammation in ischemic stroke: Insights from high altitude hypoxia","volume":"608","author":"Khan","year":"2026","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0275","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1038\/ncomms7340","article-title":"The HIF-1\/glial TIM-3 axis controls inflammation-associated brain damage under hypoxia","volume":"6","author":"Koh","year":"2015","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0285","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jep.2014.12.068","article-title":"Pharmacokinetic profiles of hydroxysafflor yellow A following intravenous administration of its pure preparations in healthy Chinese volunteers","volume":"162","author":"Li","year":"2015","journal-title":"Journal of Ethnopharmacology"},{"issue":"01","key":"10.1016\/j.pharmthera.2026.109103_bb0290","first-page":"39","article-title":"Research progress on the extraction method and content determination of Hydroxyflavone A from red flowers","volume":"32","author":"Li","year":"2018","journal-title":"Journal of China-Japan Friendship Hospital"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109103_bb0295","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.apsb.2017.04.005","article-title":"Isocartormin, a novel quinochalcone C-glycoside from Carthamus tinctorius","volume":"7","author":"Li","year":"2017","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0300","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s12975-014-0354-x","article-title":"Evaluation of the protective potential of brain microvascular endothelial cell autophagy on blood\u2013brain barrier integrity during experimental cerebral ischemia\u2013reperfusion injury","volume":"5","author":"Li","year":"2014","journal-title":"Translational Stroke Research"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0310","article-title":"Comparative efficacy of Honghua class injections for treating acute ischemic stroke: A Bayesian network meta-analysis of randomized controlled trials","volume":"13","author":"Li","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109103_bb0315","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/svn-2021-000978","article-title":"Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): A multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study","volume":"7","author":"Li","year":"2021","journal-title":"Stroke and Vascular Neurology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109103_bb0320","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12943-020-1138-4","article-title":"Autophagy and autophagy-related proteins in cancer","volume":"19","author":"Li","year":"2020","journal-title":"Molecular Cancer"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109103_bb0325","first-page":"728","article-title":"Hydroxysafflor Yellow A blocks HIF-1\u03b1 induction of NOX2 and Protects ZO-1 protein in cerebral microvascular endothelium","volume":"11","author":"Li","year":"2022","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109103_bb0330","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/01.STR.0000089015.51603.CC","article-title":"Inflammation and infections as risk factors for ischemic stroke","volume":"34","author":"Lindsberg","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0335","first-page":"773","article-title":"Research progress on the neuroprotective mechanism of hydroxysafflor Yellow A on ischemic stroke","volume":"10","author":"Liu","year":"2022","journal-title":"Journal of Chinese Pharmaceutical Sciences"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109103_bb0340","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1007\/s12035-015-9504-8","article-title":"nitric oxide interacts with Caveolin-1 to facilitate autophagy-lysosome-mediated Claudin-5 degradation in oxygen-glucose deprivation-treated endothelial cells","volume":"53","author":"Liu","year":"2016","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0345","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.phrs.2018.05.012","article-title":"Oral hydroxysafflor Yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism","volume":"134","author":"Liu","year":"2018","journal-title":"Pharmacological Research"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.109103_bb0350","first-page":"3403","article-title":"The influence of Danhong Injection on hemorheology and micro-inflammatory state in patients with ischemic stroke","volume":"20","author":"Liu","year":"2023","journal-title":"Laboratory Medicine and Clinic"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02952","article-title":"IL-17A-mediated excessive autophagy aggravated neuronal ischemic injuries via Src-PP2B-mTOR pathway","volume":"10","author":"Liu","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109103_bb0360","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1523\/JNEUROSCI.0116-07.2007","article-title":"NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo","volume":"27","author":"Liu","year":"2007","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0365","doi-asserted-by":"crossref","DOI":"10.1007\/s12038-021-00246-3","article-title":"Hydroxysafflor yellow a can improve depressive behavior by inhibiting hippocampal inflammation and oxidative stress through regulating hpa axis","volume":"47","author":"Liu","year":"2022","journal-title":"Journal of Biosciences"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109103_bb0370","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.3390\/md13074231","article-title":"Advances in microalgae-derived phytosterols for functional food and pharmaceutical applications","volume":"13","author":"Luo","year":"2015","journal-title":"Marine Drugs"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0375","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuint.2017.10.012","article-title":"The potential mechanism for Hydroxysafflor Yellow A attenuating blood-brain barrier dysfunction via tight junction signaling pathways excavated by an integrated serial affinity chromatography and shotgun proteomics analysis approach","volume":"112","author":"Lv","year":"2018","journal-title":"Neurochemistry International"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109103_bb0380","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s10571-015-0322-3","article-title":"Hydroxysafflor Yellow A attenuates neuron damage by suppressing the lipopolysaccharide-induced TLR4 pathway in activated microglial cells","volume":"36","author":"Lv","year":"2016","journal-title":"Cellular and Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0385","first-page":"4099","article-title":"Enhanced absorption of hydroxysafflor Yellow A using a self-double-emulsifying drug delivery system: in vitro and in vivo studies","volume":"7","author":"Lv","year":"2012","journal-title":"International Journal of Nanomedicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109103_bb0390","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1161\/STROKEAHA.119.025699","article-title":"Thrombolytic therapy for acute ischemic stroke: A very great honor","volume":"50","author":"Lyden","year":"2019","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109103_bb0395","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB signaling: Navigating the network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109103_bb0400","doi-asserted-by":"crossref","first-page":"10680","DOI":"10.1096\/fj.201900070R","article-title":"Protective effects of GPR37 via regulation of inflammation and multiple cell death pathways after ischemic stroke in mice","volume":"33","author":"McCrary","year":"2019","journal-title":"FASEB Journal"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109103_bb0405","first-page":"1412","article-title":"Mechanistic study of the inflammatory response of hydroxysafflor yellow A on oxygen-glucose deprivation\/reoxygenation-induced BV2 cells","volume":"39","author":"Miao","year":"2023","journal-title":"The Chinese Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0415","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.biopha.2016.12.113","article-title":"Hydroxysafflor yellow A cardioprotection in ischemia-reperfusion (I\/R) injury mainly via Akt\/hexokinase II independent of ERK\/GSK-3\u03b2 pathway","volume":"87","author":"Min","year":"2017","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109103_bb0420","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","article-title":"Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism","volume":"7","author":"Morrison","year":"2016","journal-title":"Gut Microbes"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109103_bb0425","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2010.07.002","article-title":"The science of stroke: Mechanisms in search of treatments","volume":"67","author":"Moskowitz","year":"2010","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109103_bb0430","doi-asserted-by":"crossref","first-page":"36","DOI":"10.14797\/mdcvj.293","article-title":"Aspirin in the modern era of cardiovascular disease prevention","volume":"17","author":"Murphy","year":"2021","journal-title":"Methodist DeBakey Cardiovascular Journal"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109103_bb0435","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1016792319207","article-title":"A study of metabolites as intermediate effectors in angiogenesis","volume":"4","author":"Murray","year":"2001","journal-title":"Angiogenesis"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109103_bb0440","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jphs.2019.04.006","article-title":"Anti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases","volume":"140","author":"Nishibori","year":"2019","journal-title":"Journal of Pharmacological Sciences"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109103_bb0445","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","article-title":"Development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0450","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3389\/fphar.2018.00692","article-title":"Danhong injection reversed cardiac abnormality in brain-heart syndrome via local and remote \u03b2-adrenergic receptor signaling","volume":"9","author":"Orgah","year":"2018","journal-title":"Frontiers in Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109103_bb0455","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12017-020-08591-6","article-title":"Safflower Yellow improves synaptic plasticity in APP\/PS1 mice by regulating microglia activation phenotypes and BDNF\/TrkB\/ERK signaling pathway","volume":"22","author":"Pang","year":"2020","journal-title":"Neuromolecular Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109103_bb0460","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/STROKEAHA.121.036800","article-title":"Gut microbiota and their metabolites in stroke: A double-edged sword","volume":"53","author":"Peh","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0465","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2147\/IJN.S18821","article-title":"Enhanced effect and mechanism of water-in-oil microemulsion as an oral delivery system of hydroxysafflor Yellow A","volume":"6","author":"Qi","year":"2011","journal-title":"International Journal of Nanomedicine"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.109103_bb0470","first-page":"157","article-title":"Clinical efficacy of hydroxysafflor Yellow A injection for acute ischemic stroke with blood stasis syndrome treated","volume":"22","author":"Qin","year":"2016","journal-title":"Chinese Journal of Experimental Traditional Medical Formulae"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109103_bb0475","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41392-022-01129-1","article-title":"Correction To: Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109103_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/jbcpp-2015-0021","article-title":"Neuroprotective effect of hydroxy safflor yellow A against cerebral ischemia-reperfusion injury in rats: putative role of mPTP","volume":"27","author":"Ramagiri","year":"2016","journal-title":"Journal of Basic and Clinical Physiology and Pharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109103_bb0485","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2174\/1567202618666211109104419","article-title":"Hydroxysafflor Yellow a promotes angiogenesis in rat brain microvascular endothelial cells injured by oxygen-glucose deprivation\/reoxygenation(OGD\/R) through SIRT1-HIF-1\u03b1-VEGFA signaling pathway","volume":"18","author":"Ruan","year":"2021","journal-title":"Current Neurovascular Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109103_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.108107","article-title":"Hydroxysafflor Yellow A promotes angiogenesis of brain microvascular endothelial cells from ischemia\/reperfusion injury via glycolysis pathway in vitro","volume":"34","author":"Ruan","year":"2025","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109103_bb0495","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1523\/JNEUROSCI.1359-19.2019","article-title":"Short-chain fatty acids improve poststroke recovery via immunological mechanisms","volume":"40","author":"Sadler","year":"2020","journal-title":"The Journal of Neuroscience"},{"issue":"7975","key":"10.1016\/j.pharmthera.2026.109103_bb0500","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41586-023-06409-6","article-title":"Lactate limits CNS autoimmunity by stabilizing HIF-1\u03b1 in dendritic cells","volume":"620","author":"Sanmarco","year":"2023","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109103_bb0505","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S1474-4422(18)30336-3","article-title":"Stroke-heart syndrome: Clinical presentation and underlying mechanisms","volume":"17","author":"Scheitz","year":"2018","journal-title":"The Lancet Neurology"},{"issue":"17","key":"10.1016\/j.pharmthera.2026.109103_bb0510","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026528","article-title":"Stroke-heart syndrome: Recent advances and challenges","volume":"11","author":"Scheitz","year":"2022","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0515","article-title":"Role of NLRP3 inflammasome in myocardial ischemia-reperfusion injury and ventricular remodeling","volume":"28","author":"Shen","year":"2022","journal-title":"Medical Science Monitor"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113125","article-title":"Glutamate excitotoxicity: Potential therapeutic target for ischemic stroke","volume":"151","author":"Shen","year":"2022","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109103_bb0525","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/00498254.2019.1668983","article-title":"Plasma and cerebrospinal fluid pharmacokinetics of Hydroxysafflor Yellow A in patients with traumatic brain injury after intravenous administration of Xuebijing using LC-MS\/MS method","volume":"50","author":"Sheng","year":"2020","journal-title":"Xenobiotica"},{"issue":"34","key":"10.1016\/j.pharmthera.2026.109103_bb0530","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.2174\/092986709789760779","article-title":"Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke","volume":"16","author":"Shi","year":"2009","journal-title":"Current Medicinal Chemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109103_bb0535","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1755-5949.2012.00295.x","article-title":"Excessive autophagy contributes to neuron death in cerebral ischemia","volume":"18","author":"Shi","year":"2012","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109103_bb0540","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.tips.2021.11.001","article-title":"Physiological and pharmacological modulation of BAX","volume":"43","author":"Spitz","year":"2022","journal-title":"Trends in Pharmacological Sciences"},{"issue":"23","key":"10.1016\/j.pharmthera.2026.109103_bb0545","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.jacc.2020.10.009","article-title":"Post-stroke cardiovascular complications and neurogenic cardiac injury: JACC state-of-the-art review","volume":"76","author":"Sposato","year":"2020","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.112138","article-title":"HSYA targets the ZBP1-166R site to inhibit MAVS signaling: A potential therapeutic strategy for cerebral ischemia-reperfusion injury","volume":"136","author":"Sun","year":"2025","journal-title":"Cellular Signalling"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109103_bb0555","doi-asserted-by":"crossref","first-page":"320","DOI":"10.5551\/jat.55962","article-title":"Association of gut microbiota-dependent metabolite trimethylamine n-oxide with first ischemic stroke","volume":"28","author":"Sun","year":"2021","journal-title":"Journal of Atherosclerosis and Thrombosis"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0560","doi-asserted-by":"crossref","first-page":"19151","DOI":"10.1021\/acsomega.0c02502","article-title":"Hydroxysafflor Yellow A together with blood\u2013brain barrier regulator lexiscan for cerebral ischemia reperfusion injury treatment","volume":"5","author":"Tan","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0565","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2147\/DDDT.S288841","article-title":"MYC\/NBS1-mediated DNA damage response is involved in the inhibitory effect of Hydroxysafflor Yellow A on glioma cells","volume":"15","author":"Tang","year":"2021","journal-title":"Drug Design, Development and Therapy"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109103_bb0570","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000141653","article-title":"Hydroxysafflor Yellow A inhibits rat brain mitochondrial permeability transition pores by a free radical scavenging action","volume":"82","author":"Tian","year":"2008","journal-title":"Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109103_bb0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2010.02.023","article-title":"Pharmacokinetic comparisons of hydroxysafflower Yellow A in normal and blood stasis syndrome rats","volume":"129","author":"Tian","year":"2010","journal-title":"Journal of Ethnopharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109103_bb0580","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jcsm.12335","article-title":"Experimental ischaemic stroke induces transient cardiac atrophy and dysfunction","volume":"10","author":"Veltkamp","year":"2019","journal-title":"Journal of Cachexia, Sarcopenia and Muscle"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109103_bb0585","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1161\/01.STR.31.10.2325","article-title":"Proinflammatory cytokines and early neurological worsening in ischemic stroke","volume":"31","author":"Vila","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0590","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.782760","article-title":"Acute heart failure after reperfused ischemic stroke: Association with systemic and cardiac inflammatory responses","volume":"12","author":"Vornholz","year":"2021","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177789","article-title":"Hydroxysafflor Yellow A alleviates ischemic myocardial injury by targeting SF3A1 to improve mitochondrial energy metabolism","volume":"1002","author":"Wang","year":"2025","journal-title":"European Journal of Pharmacology"},{"issue":"01","key":"10.1016\/j.pharmthera.2026.109103_bb0600","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5428\/pcar20160115","article-title":"Concentration determination of Hydroxysafflor Yellow A in the plasma of the patients with renal insufficiency by HPLC method","volume":"16","author":"Wang","year":"2016","journal-title":"Pharmaceutical Care and Research"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0605","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3389\/fneur.2018.00998","article-title":"Endothelial Atg7 deficiency ameliorates acute cerebral injury induced by ischemia\/reperfusion","volume":"9","author":"Wang","year":"2018","journal-title":"Frontiers in Neurology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109103_bb0610","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/jcmm.13111","article-title":"Qiliqiangxin protects against anoxic injury in cardiac microvascular endothelial cells via NRG-1\/ErbB-PI3K\/Akt\/mTOR pathway","volume":"21","author":"Wang","year":"2017","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109103_bb0615","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1038\/s41467-025-59774-3","article-title":"Elucidation of the biosynthetic pathway of Hydroxysafflor Yellow A","volume":"16","author":"Wang","year":"2025","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0620","article-title":"Hydroxysafflor yellow A protects neurons from excitatory death through inhibition of NMDA receptors","author":"Wang","year":"2015","journal-title":"Binzhou Medical University."},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109103_bb0625","doi-asserted-by":"crossref","DOI":"10.1177\/1759091416642345","article-title":"Hydroxysafflor Yellow A protects neurons from excitotoxic death through inhibition of nmdars","volume":"8","author":"Wang","year":"2016","journal-title":"ASN Neuro"},{"issue":"35","key":"10.1016\/j.pharmthera.2026.109103_bb0630","first-page":"1","article-title":"Brain-heart integration therapy is a highly innovative clinical field","volume":"32","author":"Wang","year":"2025","journal-title":"China Modern Medicine"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0635","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.986511","article-title":"The SIRT1-HMGB1 axis: Therapeutic potential to ameliorate inflammatory responses and tumor occurrence","volume":"10","author":"Wei","year":"2022","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"23","key":"10.1016\/j.pharmthera.2026.109103_bb0640","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.3390\/cells11233726","article-title":"Hydroxysafflor Yellow A exerts neuroprotective effects via HIF-1\u03b1\/BNIP3 pathway to activate neuronal autophagy after OGD\/R","volume":"11","author":"Wei","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109103_bb0645","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jchromb.2008.10.007","article-title":"A rapid and sensitive liquid chromatography-tandem mass spectrometry (LC-MS\/MS) method for the determination of Hydroxysafflor Yellow A in human plasma: Application to a pharmacokinetic study","volume":"876","author":"Wen","year":"2008","journal-title":"Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109103_bb0655","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jms.4041","article-title":"A comprehensive in vitro and in vivo metabolism study of Hydroxysafflor Yellow A","volume":"53","author":"Wu","year":"2018","journal-title":"Journal of Mass Spectrometry: JMS"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153884","article-title":"Ligustilide attenuates ischemic stroke injury by promoting Drp1-mediated mitochondrial fission via activation of AMPK","volume":"95","author":"Wu","year":"2022","journal-title":"Phytomedicine"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109103_bb0665","article-title":"The current status, dilemmas, and breakthrough strategies of \u201cco-treatment of brain and heart\u201d for comorbid cerebrocardiovascular disease","volume":"20","author":"Wu","year":"2025","journal-title":"Chinese Journal of Stroke"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109103_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167867","article-title":"Hydroxysafflor Yellow A inhibits neuronal ferroptosis and ferritinophagy in ischemic stroke","volume":"1871","author":"Wu","year":"2025","journal-title":"Biochimica et Biophysica Acta, Molecular Basis of Disease"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0675","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3389\/fneur.2019.00397","article-title":"Stroke Dysbiosis Index (SDI) in gut microbiome are associated with brain injury and prognosis of stroke","volume":"10","author":"Xia","year":"2019","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113462","article-title":"Comprehensive review of two groups of flavonoids in Carthamus tinctorius L","volume":"153","author":"Xian","year":"2022","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109103_bb0685","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/15548627.2015.1132134","article-title":"Neuroprotection by selective neuronal deletion of Atg7 in neonatal brain injury","volume":"12","author":"Xie","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0690","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8214128","article-title":"Hydroxysafflor Yellow A attenuates hydrogen peroxide-induced oxidative damage on human umbilical vein endothelial cells","volume":"2020","author":"Xie","year":"2020","journal-title":"Evidence-based Complementary and Alternative Medicine: Ecam"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0695","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1136\/gutjnl-2020-323263","article-title":"Rapid gut dysbiosis induced by stroke exacerbates brain infarction in turn","volume":"70","author":"Xu","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0700","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.redox.2018.06.012","article-title":"Breast cancer susceptibility protein 1 (BRCA1) rescues neurons from cerebral ischemia\/reperfusion injury through NRF2-mediated antioxidant pathway","volume":"18","author":"Xu","year":"2018","journal-title":"Redox Biology"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.109103_bb0705","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1111\/bph.15261","article-title":"Arctigenin protects against depression by inhibiting microglial activation and neuroinflammation via HMGB1\/TLR4\/NF-\u03baB and TNF-\u03b1\/TNFR1\/NF-\u03baB pathways","volume":"177","author":"Xu","year":"2020","journal-title":"British Journal of Pharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109103_bb0710","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179586","article-title":"Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway","volume":"12","author":"Yan","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109103_bb0715","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/jcbfm.2013.242","article-title":"NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke","volume":"34","author":"Yang","year":"2014","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0720","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.brainresbull.2018.05.011","article-title":"Hydroxysafflor Yellow A protects brain microvascular endothelial cells against oxygen glucose deprivation\/reoxygenation injury: Involvement of inhibiting autophagy via class I PI3K\/Akt\/mTOR signaling pathway","volume":"140","author":"Yang","year":"2018","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0725","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.redox.2018.03.002","article-title":"Diverse roles of mitochondria in ischemic stroke","volume":"16","author":"Yang","year":"2018","journal-title":"Redox Biology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109103_bb0730","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s11064-010-0191-6","article-title":"Neuroprotective effects of Hydroxysafflor Yellow A against excitotoxic neuronal death partially through down-regulation of NR2B-containing NMDA receptors","volume":"35","author":"Yang","year":"2010","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114040","article-title":"Hydroxysafflor Yellow A attenuates the inflammatory response in cerebral ischemia-reperfusion injured mice by regulating microglia polarization per SIRT1-mediated HMGB1\/NF-\u03baB signaling pathway","volume":"147","author":"Yao","year":"2025","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0740","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3389\/fphar.2020.01170","article-title":"Hydroxysafflor Yellow A protects against myocardial ischemia\/reperfusion injury via suppressing NLRP3 inflammasome and activating autophagy","volume":"11","author":"Ye","year":"2020","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0745","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6643615","article-title":"Hydroxysafflor Yellow A Ameliorates myocardial ischemia\/reperfusion injury by suppressing calcium overload and apoptosis","volume":"2021","author":"Ye","year":"2021","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0750","article-title":"Injection of hydeoxysafflor yellow A in treatment of 64 cases of actue cerebral infarction a clinical study","author":"Yin","year":"2012","journal-title":"Hubei University of Chinese Medicine"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0755","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3389\/fncel.2018.00371","article-title":"Hydroxysafflor Yellow A (HSYA) improves learning and memory in cerebral ischemia reperfusion-injured rats via recovering synaptic plasticity in the hippocampus","volume":"12","author":"Yu","year":"2018","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109103_bb0760","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s10571-020-00812-7","article-title":"Hydroxysafflor Yellow A confers neuroprotection from focal cerebral ischemia by modulating the crosstalk between JAK2\/STAT3 and SOCS3 signaling pathways","volume":"40","author":"Yu","year":"2020","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109103_bb0765","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.jcbfm.9600378","article-title":"Stroke-evoked angiogenesis results in a transient population of microvessels","volume":"27","author":"Yu","year":"2007","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109103_bb0770","doi-asserted-by":"crossref","first-page":"15220","DOI":"10.3390\/molecules181215220","article-title":"Chemical and biological properties of quinochalcone C-glycosides from the florets of Carthamus tinctorius","volume":"18","author":"Yue","year":"2013","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109103_bb0775","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40779-022-00383-2","article-title":"Activated Drp1 regulates p62-mediated autophagic flux and aggravates inflammation in cerebral ischemia-reperfusion via the ROS-RIP1\/RIP3-exosome axis","volume":"9","author":"Zeng","year":"2022","journal-title":"Military Medical Research"},{"issue":"08","key":"10.1016\/j.pharmthera.2026.109103_bb0780","first-page":"940","article-title":"Effect of danhong injection on carotid plaque and serum C-reactive protein in patients with acute ischemic stroke","volume":"9","author":"Zhang","year":"2023","journal-title":"Journal of Vascular and Endovascular Surgery"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109103_bb0785","first-page":"456","article-title":"Pharmacokinetics of Hydroxysafflor Yellow A in rats","volume":"37","author":"Zhang","year":"2006","journal-title":"Journal of China Pharmaceutical University"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109103_bb0790","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s12264-013-1375-2","article-title":"Hydroxysafflor Yellow A improves learning and memory in a rat model of vascular dementia by increasing VEGF and NR1 in the hippocampus","volume":"30","author":"Zhang","year":"2014","journal-title":"Neuroscience Bulletin"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0800","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/4560012","article-title":"Pharmacological actions, molecular mechanisms, pharmacokinetic progressions, and clinical applications of Hydroxysafflor Yellow A in antidiabetic research","volume":"2021","author":"Zhang","year":"2021","journal-title":"Journal of Immunology Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109103_bb0805","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.4161\/auto.25132","article-title":"Cerebral ischemia-reperfusion-induced autophagy protects against neuronal injury by mitochondrial clearance","volume":"9","author":"Zhang","year":"2013","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109103_bb0810","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1142\/S0192415X22500331","article-title":"Hydroxysafflor Yellow A alleviates ischemic stroke in rats via HIF-1\u03b1, BNIP3, and Notch1-Mediated inhibition of autophagy","volume":"50","author":"Zhang","year":"2022","journal-title":"The American Journal of Chinese Medicine"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109103_bb0815","doi-asserted-by":"crossref","first-page":"8658","DOI":"10.3390\/ijms24108658","article-title":"Nanoemulsions of Hydroxysafflor Yellow A for enhancing physicochemical and in vivo performance","volume":"24","author":"Zhang","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"34","key":"10.1016\/j.pharmthera.2026.109103_bb0820","first-page":"60","article-title":"The clinical efficacy of Danhong Injection in the treatment of transient ischemic attack","volume":"15","author":"Zhang","year":"2022","journal-title":"Chinese Journal of Clinical Rational Drug Use"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0825","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijpharm.2017.10.040","article-title":"Solid lipid nanoparticles as carriers for oral delivery of Hydroxysafflor Yellow A","volume":"535","author":"Zhao","year":"2018","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156868","article-title":"Hydroxysafflor Yellow A ameliorates myocardial ischemia\/reperfusion injury by promoting MDH1-mediated mitochondrial metabolic homeostasis","volume":"144","author":"Zhao","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0835","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.579332","article-title":"Hydroxysafflor Yellow A: A systematical review on botanical resources, physicochemical properties, drug delivery system, pharmacokinetics, and pharmacological effects","volume":"11","author":"Zhao","year":"2020","journal-title":"Frontiers in Pharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109103_bb0840","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14818","article-title":"GSK3: A potential target and pending issues for treatment of Alzheimer's disease","volume":"30","author":"Zhao","year":"2024","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109103_bb0845","first-page":"1596","article-title":"Prevention and treatment strategy of cardiovascular and cerebrovascular diseases guided by the theory of \"simultaneous treatment of brain and heart\"","volume":"33","author":"Zhao","year":"2013","journal-title":"Chinese Journal of Integrated Traditional and Western Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109103_bb0850","first-page":"520","article-title":"The effect of hydroxy safflower Yellow A on coronary heart disease through Bcl-2\/Bax and PPAR-\u03b3","volume":"15","author":"Zhou","year":"2018","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109103_bb0855","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.neuron.2025.10.022","article-title":"C5aR1+ microglia exacerbate neuroinflammation and cerebral edema in acute brain injury","volume":"114","author":"Zhou","year":"2026","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109103_bb0860","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2174\/1381612829666230313111314","article-title":"Cyclophilin D-mediated mitochondrial permeability transition regulates mitochondrial function","volume":"29","author":"Zhou","year":"2023","journal-title":"Current Pharmaceutical Design"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109103_bb0865","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0002-9440(10)64242-3","article-title":"Regulation of angiogenesis by vascular endothelial growth factor and angiopoietin-1 in the rat aorta model: distinct temporal patterns of intracellular signaling correlate with induction of angiogenic sprouting","volume":"161","author":"Zhu","year":"2002","journal-title":"The American Journal of Pathology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109103_bb0870","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","article-title":"Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk","volume":"165","author":"Zhu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0875","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5853\/jos.2022.02173","article-title":"The heart is at risk: Understanding stroke-heart-brain interactions with focus on neurogenic stress cardiomyopathy\u2014A review","volume":"25","author":"Ziaka","year":"2023","journal-title":"Journal of Stroke"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109103_bb0880","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1111\/jcmm.13552","article-title":"Nucleolin mediated pro-angiogenic role of Hydroxysafflor Yellow A in ischaemic cardiac dysfunction: Post-transcriptional regulation of VEGF-A and MMP-9","volume":"22","author":"Zou","year":"2018","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2026.109103_bb0885","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuropharm.2014.07.002","article-title":"Mitochondria autophagy is induced after hypoxic\/ischemic stress in a drp1 dependent manner: The role of inhibition of drp1 in ischemic brain damage","volume":"86","author":"Zuo","year":"2014","journal-title":"Neuropharmacology"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826001300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826001300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:58:30Z","timestamp":1794412710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725826001300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":172,"alternative-id":["S0163725826001300"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109103","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospects for treatment of cerebral ischemic stroke with Hydroxysafflower Yellow A","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109103"}}